椎动脉型颈椎病采用脊柱微调主体疗法的预期评价

Prospective evaluation in treating vertebral artery type of cervical spondylosis with Spinal fine adjusting body therapy

目的:评价椎动脉型颈椎病采用脊柱微调主体疗法的临床预期。方法:临床组患者在脊柱微调疗法基础上辅以常规手法进行治疗。参照组单纯口服氟桂利嗪进行治疗。结果:两组症状积分均比治疗前显著改善,而临床组改善显著优于参照组(P<0.05或P<0.01)。两组治疗后颈椎动脉痉挛改善明显(P<0.05),但组间对比无明显差异。两组治疗后寰枢关节位移指数均显著改善(P<0.05),而临床组改善幅度显著优于参照组(P<0.05)。结论:椎动脉型颈椎病采用脊柱微调主体疗法进行治疗可显著缓解症状,优化颈椎正常解剖结构,安全性好,故临床疗效确切。

Objective：To evaluation the clinical expectation in treating vertebral artery type of cervical spondylosis with Spinal fine adjusting body therapy. Methods： The clinical patients in the spinal fine adjusting therapy combined with conventional techniques for treatment. The reference group treated with flunarizine treatment. Results： The two groups symptoms were significantly improved than before treatment and the clinical group improved significantly better than the control group （P〈0.05 or P〈0.01）. Cervical artery spasm improved significantly after the treatment in the two groups （P〈0.05）, but no significant difference between group comparison. The two groups after treatment of atlantoaxial joint displacement index were improved significantly （P〈0.05）, and clinical improvement was significantly better than the reference group （P〈0.05）. Conclusion：Treating vertebral artery type of cervical spondylosis with Spinal fine adjusting body therapy can significantly relieve the symptoms of cervical vertebra, normal anatomical structure optimization, good safety, the clinical curative effect.